COST-EFFECTIVENESS OF BIOLOGICAL TREATMENTS IN PATIENTS WITH RHEUMATOID ARTHRITIS IN TAIWAN

被引：0
|
作者：
Chen, H. F. [1 ]
Lin, H. Y. [2 ]
Lang, H. C. [1 ]
机构：
[1] Natl Yang Ming Univ, Taipei 112, Taiwan
[2] Vet Gen Hosp, Taipei, Taiwan
来源：
VALUE IN HEALTH | 2012年 / 15卷 / 07期
关键词：
D O I：
10.1016/j.jval.2012.08.414
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A673 / A673
页数：1
相关论文
共 50 条
  • [1] A cost-effectiveness analysis of biological treatments for rheumatoid arthritis
    Chiou, CF
    Wanke, L
    Yu, E
    Ofman, J
    [J]. VALUE IN HEALTH, 2004, 7 (03) : 223 - 223
  • [2] Cost-effectiveness analysis of rituximab for rheumatoid arthritis in Taiwan
    Lou, S. F.
    Chen, D. Y.
    Cheng, T. T.
    Huang, C. M.
    Lin, H. Y.
    Su, C. C.
    Tsai, W. C.
    Tseng, J. C.
    Wei, C. C.
    Yang, L.
    Hazard, S.
    Chang, D. M.
    [J]. VALUE IN HEALTH, 2008, 11 (03) : A257 - A258
  • [3] The cost-effectiveness of biological drugs for rheumatoid arthritis: a systematic review
    Joensuu, J. T.
    Aaltonen, K. J.
    Nordstrom, D.
    Konttinen, Y. T.
    Blom, M.
    [J]. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2014, 43 (05) : 434 - 435
  • [4] COST-EFFECTIVENESS OF TOFACITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS IN CHINA
    Wang, B. C.
    Chen, Y.
    Furnback, W.
    Wu, Q.
    Dong, P.
    [J]. VALUE IN HEALTH, 2018, 21 : S197 - S197
  • [5] Cost-Effectiveness of Cardiovascular Screening in Patients With Rheumatoid Arthritis
    Kievit, Wietske
    Maurits, Jake S. F.
    Arts, Elke E.
    van Riel, Piet L. C. M.
    Fransen, Jaap
    Popa, Calin D.
    [J]. ARTHRITIS CARE & RESEARCH, 2017, 69 (02) : 175 - 182
  • [6] A systematic review of cost-effectiveness analyses of biological DMARDs in rheumatoid arthritis
    Richard, L.
    Brown, M.
    [J]. VALUE IN HEALTH, 2007, 10 (06) : A245 - A246
  • [7] Cost-Effectiveness of Biosimilars vs Leflunomide in Patients With Rheumatoid Arthritis
    Peng, Kuan
    Chan, Shirley C. W.
    Wang, Yang
    Cheng, Franco W. T.
    Yeung, Winnie W. Y.
    Jiao, Yuanshi
    Chan, Esther W. Y.
    Wong, Ian C. K.
    Lau, Chak-Sing
    Li, Xue
    [J]. JAMA NETWORK OPEN, 2024, 7 (06)
  • [8] Sequences of biological treatments for patients with moderate-to-severe rheumatoid arthritis in the era of treat-to-target in China: a cost-effectiveness analysis
    Chongqing Tan
    Xia Luo
    Sini Li
    Lidan Yi
    Xiaohui Zeng
    Liubao Peng
    Shuxia Qin
    Liting Wang
    Xiaomin Wan
    [J]. Clinical Rheumatology, 2022, 41 : 63 - 73
  • [9] Sequences of biological treatments for patients with moderate-to-severe rheumatoid arthritis in the era of treat-to-target in China: a cost-effectiveness analysis
    Tan, Chongqing
    Luo, Xia
    Li, Sini
    Yi, Lidan
    Zeng, Xiaohui
    Peng, Liubao
    Qin, Shuxia
    Wang, Liting
    Wan, Xiaomin
    [J]. CLINICAL RHEUMATOLOGY, 2022, 41 (01) : 63 - 73
  • [10] Cost-effectiveness of biological therapy compared with methotrexate in the treatment for rheumatoid arthritis in Colombia
    Carolina Valle-Mercado
    Maria-Fernanda Cubides
    Monica Parra-Torrado
    Diego Rosselli
    [J]. Rheumatology International, 2013, 33 : 2993 - 2997
12345